CROs/Service Providers

Exco InTouch focuses on Valued Partner Network

Thursday, February 25, 2016

Exco InTouch has expanded the company’s global reach, launching a Valued Partner Network that provides extensive support to CROs and technology service providers by integrating market leading patient engagement and electronic Clinical Outcome Assessment (eCOA) capabilities into their existing service portfolios.

[Read More]

Parexel expands genomic research services

Thursday, February 25, 2016

Parexel International, a global biopharmaceutical services organization, has announced expanded services and capabilities in genomic-based drug development. The Parexel Genomic Medicine team offers clients a variety of strategic and operational genomic research services to accelerate drug development and to support regulatory and payer approval processes.

[Read More]

BioAgilytix acquires IPM Biotech

Tuesday, February 23, 2016

BioAgilytix, a provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has announced the acquisition of IPM Biotech, a German-based bioanalytical contract research laboratory known for its expertise in large molecule bioanalysis, particularly in the area of immunogenicity.

[Read More]

PPD expands Preclarus

Wednesday, February 17, 2016

Global CRO Pharmaceutical Product Development (PPD) is expanding Preclarus, a clinical data platform, to include a comprehensive set of data solutions that supports the company’s central lab operations. These changes will enable study sites to access clean central lab data in real time, improve inventory management and order tracking, facilitate patient management and safety, and establish complete chain of custody for samples. The goal of these enhancements is to increase the efficiency and effectiveness of managing central lab data for PPD’s clients.

[Read More]

INC launches Catalyst Program for research site collaboration

Wednesday, February 17, 2016

INC Research, a global phase I to IV CRO, has launched its Catalyst program to strengthen collaborations with clinical research sites worldwide, in turn enhancing patient focus and optimizing study delivery to drive improved predictability of clinical trials and reduce development timelines for biopharmaceutical customers worldwide. 

[Read More]

Recipharm pours €40M into serialization

Tuesday, February 16, 2016

Recipharm, a contract development and manufacturing organization (CDMO), has taken the decision to lead the market in coding and serialization to actively help pharmaceutical companies prepare for the implementation of new regulations. 

[Read More]